Add BrightSurf on Google Email

Stanford Medicine


Low-fat or low-carb? It's a draw, Stanford study finds

A Stanford University School of Medicine study found that cutting carbs or fats results in similar weight loss, with no association between individual biological factors and diet success. Participants followed either a low-fat or low-carb diet for one year, showing that the fundamental strategy for losing weight is to eat whole foods.

SourceStanford Medicine·JournalJAMA·DateFeb 20, 2018

Use of chemotherapy for early stage breast cancer declines, Stanford-led study says

A Stanford-led study of nearly 3,000 women with early stage breast cancer reveals a significant decline in chemotherapy use between 2013 and 2015, from 34.5% to 21.3%. This decrease reflects a growing trend towards personalized treatment approaches, with physicians increasingly considering tumor genomic testing to guide treatment choices.

SourceStanford Medicine·JournalJNCI Journal of the National Cancer Institute·DateDec 11, 2017

After medical error, apology goes a long way

A study published in Health Affairs found that communication-and-resolution programs significantly improve patient safety while reducing liability costs. The programs, which include apologies and explanations for medical errors, lead to a low percentage of events resulting in lawsuits, with only 5% leading to malpractice claims.

SourceStanford Medicine·JournalHealth Affairs·DateOct 2, 2017

Stanford study shows how 'love hormone' spurs sociability

Researchers at Stanford University School of Medicine have identified the brain circuitry behind social reward, pinpointing oxytocin as a key player. The study suggests that oxytocin promotes sociability by binding to receptors on dopamine-secreting neurons, enhancing their firing and fostering positive social interactions.

SourceStanford Medicine·JournalScience·DateSep 28, 2017

Stanford researchers identify biomarkers associated with chronic fatigue syndrome severity

Researchers at Stanford University School of Medicine have identified biomarkers associated with chronic fatigue syndrome severity by analyzing 17 immune-system signaling proteins. These findings suggest that inflammation is a powerful driver of the disease and may lead to improved diagnosis and treatment options.

SourceStanford Medicine·JournalProceedings of the National Academy of Sciences·DateJul 31, 2017